When was NeuroSigma founded?

NeuroSigma was founded in 2008 and raised its 1st funding round 2 years after it was founded.

Where is NeuroSigma located?

NeuroSigma is headquartered in Los Angeles, United States.

Who is the current CEO of NeuroSigma?

Leon Ekchian of NeuroSigma. They have also founded 1 company.

How many employees does NeuroSigma have?

As of Dec 31, 2019, the latest employee count at NeuroSigma is 8.

Is NeuroSigma a funded company?

NeuroSigma is a funded company, having raised a total of $2.92M across 14 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Jun 08, 2010.

When was the latest funding round of NeuroSigma?

NeuroSigma's latest funding was a $***** Post IPO round on Dec 08, 2021, with participation from 1 investor. Its primary sector is Neurology. In United States, the Neurology sector has seen $3.1B in funding in 2026 to date.

Where does NeuroSigma rank among its competitors?

NeuroSigma ranks 7th amongst 198 active competitors, of which 59 are funded. It stands 9th in terms of total funding among its competitors. The most recent competitor to raise funding was Neurolief, which secured $6M in Mar, 2026.

Who are the top competitors of NeuroSigma?

NeuroSigma's top competitors include Muse, Apollo Neuroscience and Cumulus Neuro. Among them, Neurolief secured the most recent funding round in March, 2026.

NeuroSigma - 2026 Company Profile, Team, Funding & Competitors

Company Details

NeuroSigma, Inc. is a medical device company focused on commercialization of its unique Trigeminal Nerve Stimulation (TNS) technology, and has a growing pipeline of treatments targeting epilepsy, depression, attention deficit hyperactivity disorder (ADHD), and post-traumatic stress disorder (PTSD). NeuroSigma is actively engaged in preclinical research and development, as well as groundbreaking Phase I, II, & III clinical trials.

Website: www.neurosigma.com/
Social

Key Metrics

Founded Year

2008

Location

Los Angeles, United States

Stage

Public

Total Funding

$2.92M in 14 rounds

Latest Funding Round

Post IPO, Dec 08, 2021, $*****

Investors

Checkmate Capital & 3 more

Ranked

7^th among 198 active competitors

Employee Count

8 as on Dec 31, 2019

Similar Companies

Freespira & 186 more

Exit Details

Public

View NeuroSigma's full profile

NeuroSigma is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Neurosigma, Inc. CIN: 1494756 , United States, Active	Aug 25, 2019	-	8 (As on Dec 31, 2019)	-

NeuroSigma got listed on Sep 30, 2014.

Click here to take a look at NeuroSigma's IPO in detail

NeuroSigma has raised a total funding of $2.92M over 14 rounds. Its first funding round was on Jun 08, 2010. Its latest funding round was a Post IPO round on Dec 08, 2021 for $*****. 1 investor participated in its latest round. NeuroSigma has 4 institutional investors.

Here is the list of recent funding rounds of NeuroSigma:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Dec 08, 2021	6429176	Post IPO	6714709	5601287	4177123	3185310
Sep 21, 2020	4148672	Post IPO	2262590	4232910	8244282	Checkmate Capital
Sep 20, 2018	3613786	Grant (prize money)	9289086	6449803	4458950	HHS

Access funding benchmarks and valuations. Sign up today!

View details of NeuroSigma's funding rounds and investors

The founders of NeuroSigma is Leon Ekchian. Leon Ekchian is the CEO of NeuroSigma.

Here are the details of NeuroSigma's key team members:

Leon Ekchian: Co-Founder & CEO of NeuroSigma.
Contact Info: 1 email address

View details of NeuroSigma's Founder profiles and Board Members

NeuroSigma's employee count trend

NeuroSigma has 8 employees as of Dec 19. Here is NeuroSigma's employee count trend over the years:

Uncover NeuroSigma's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of NeuroSigma include Muse, Apollo Neuroscience and Cumulus Neuro. Here is the list of Top 10 competitors of NeuroSigma, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Muse 2007, Toronto (Canada), Series C	Provider of brainwave tracking devices and related premium subscription services	$57.4M	OMERS, Export Development Canada & 22 others	68/100
2nd	Apollo Neuroscience 2017, Pittsburgh (United States), Series A	Developer of wearable technology for stress reduction, sleep improvement, and performance enhancement	$30.7M	Noetic Psychedelic Fund, Republic Capital ... & 8 others	62/100
3rd	Cumulus Neuro 2015, Belfast (United Kingdom), Series A	AI and cloud-based brain physiology analysis tool for clinical trials	$19.6M	Par Equity, Innovate UK & 29 others	61/100
4th	Flow Neuroscience 2016, Malmo (Sweden), Series A	Provider of a wearable device for stress and anxiety management	$11.9M	Khosla Ventures, HAX & 6 others	61/100
5th	Freespira 2008, Danville (United States), Series D	Medical device & Mobile app to treat panic disorders	$48.9M	Aphelion Capital, Lightspeed Venture Partners ... & 4 others	60/100
6th	Motif neurotech 2022, Houston (United States), Series A	Developer of minimally invasive bioelectronics for mental health disorders	$18.8M	Arboretum Ventures, re.Mind Capital & 9 others	60/100
7th	NeuroSigma 2008, Los Angeles (United States), Public	Develops and commercializes trigeminal nerve stimulation (TNS) devices for treatment of psychiatric disorders	$2.92M	Checkmate Capital, NINDS & 2 others	59/100
8th	Hapbee 2004, Phoenix (United States), Public	Retailer of wearable technology products designed to improve sleep and wellness	$4.8M	Smile Group, Incisive Ventures	59/100
9th	Neurolief 2012, Herzliya (Israel), Series A	Wearable device for neurological and neuropsychiatric disorders	$11M	Champel Capital, Terra Venture Partners & 2 others	59/100
10th	Mave Health 2023, Bengaluru (India), Seed	Provider of NIBS wearable device designed to improve brain health	$2.85M	Blume Venture, iSeed & 25 others	58/100